報價延遲最少15分鐘:2025/01/11 17:51 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
12.41 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-2.41/-0.11
|
|
企業價值
996.90M
|
| 資產負債 |
|
每股賬面淨值
0.70
|
| 現金流量 |
|
現金流量率
0.01
|
| 損益表 |
|
收益
139.91M
|
|
每股收益
2.35
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/11 17:51 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized intoone reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization. |